Home NDC 59262-355 Computer Eye Relief
Product NDC 59262-355
11-digit product format 592620355
Labeler code 59262
Product ID 59262-355_d4940e00-4f2f-4e82-827a-fb91870bd454
Type HUMAN OTC DRUG
Nonproprietary name Conium maculatum, Natrium muriaticum, Ruta graveolens, Senega officinalis
Dosage form SOLUTION/ DROPS
Route OPHTHALMIC
Labeler Similasan Corporation
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2011-07-01
Marketing end 0000-00-00
Substance CONIUM MACULATUM FLOWERING TOP; SODIUM CHLORIDE; RUTA GRAVEOLENS FLOWERING TOP; POLYGALA SENEGA ROOT
Active strength 6 [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL; [hp_X]/.45mL
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 50 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 59262-355-01 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 59262-355-13 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 59262-355-01 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 59262-355-13 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 59262-355-01 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 59262-355-13 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 59262-355-01 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 59262-355-13 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 59262-355-01 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 59262-355-13 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 59262-355-01 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 59262-355-13 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 59262-355-01 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 59262-355-13 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 59262-355-01 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 59262-355-13 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 59262-355-01 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 59262-355-13 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 59262-355-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 59262-355-13 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 59262-355-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 59262-355-13 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 59262-355-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 59262-355-13 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 59262-355-01 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 59262-355-01 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 59262-355-01 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 59262-355-01 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 59262-355-01 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 59262-355-01 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 59262-355-01 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59262-355-01 Computer Eye Relief 200 in 1 CARTON SOLUTION/ DROPS 200 10 59262-355-01 Computer Eye Relief .45 mL in 1 VIAL, SINGLE-USE SOLUTION/ DROPS .45 10 59262-355-13 Computer Eye Relief .45 mL in 1 VIAL, SINGLE-USE SOLUTION/ DROPS .45 10
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CONIUM MACULATUM FLOWERING TOP ACTIVE INGREDIENT Q28R5GF371 COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 POLYGALA SENEGA ROOT ACTIVE INGREDIENT M7T6H7D4IF COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 RUTA GRAVEOLENS FLOWERING TOP ACTIVE INGREDIENT N94C2U587S COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 SODIUM CHLORIDE ACTIVE INGREDIENT 451W47IQ8X COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 CONIUM MACULATUM FLOWERING TOP ACTIVE MOIETY Q28R5GF371 COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 POLYGALA SENEGA ROOT ACTIVE MOIETY M7T6H7D4IF COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 RUTA GRAVEOLENS FLOWERING TOP ACTIVE MOIETY N94C2U587S COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 SODIUM CATION ACTIVE MOIETY LYR4M0NH37 COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS INACTIVE INGREDIENT 22ADO53M6F COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE INACTIVE INGREDIENT 5QWK665956 COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6 WATER INACTIVE INGREDIENT 059QF0KO0R COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59262-355 COMPUTER EYE RELIEF (CONIUM MACULATUM, NATRIUM MURIATICUM, RUTA GRAVEOLENS, SENEGA OFFICINALIS) SOLUTION/ DROPS [SIMILASAN CORPORATION] 10 Legacy NDC, 3 package rows 20190321_a8e9f9f8-bc15-495f-8f6d-bd21c7379be8.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 59262-355-01 59262035501 200 in 1 CARTON Historical 59262-355-13 59262035513 .45 mL in 1 VIAL, SINGLE-USE Historical